S&P 500   4,567.56 (+0.28%)
DOW   35,539.90 (+0.35%)
QQQ   391.28 (+0.28%)
AAPL   189.88 (-0.27%)
MSFT   378.28 (-1.15%)
META   333.82 (-1.53%)
GOOGL   135.65 (-1.13%)
AMZN   146.44 (-0.40%)
TSLA   247.95 (+0.50%)
NVDA   482.19 (+0.83%)
NIO   7.23 (+0.28%)
BABA   74.78 (-2.55%)
AMD   124.60 (+2.12%)
T   16.24 (+0.37%)
F   10.63 (+2.51%)
MU   77.28 (+1.52%)
CGC   0.55 (+1.81%)
GE   119.45 (+0.50%)
DIS   92.88 (+0.41%)
AMC   7.06 (+5.37%)
PFE   30.03 (+1.15%)
PYPL   58.64 (+0.29%)
XOM   103.11 (-0.76%)
S&P 500   4,567.56 (+0.28%)
DOW   35,539.90 (+0.35%)
QQQ   391.28 (+0.28%)
AAPL   189.88 (-0.27%)
MSFT   378.28 (-1.15%)
META   333.82 (-1.53%)
GOOGL   135.65 (-1.13%)
AMZN   146.44 (-0.40%)
TSLA   247.95 (+0.50%)
NVDA   482.19 (+0.83%)
NIO   7.23 (+0.28%)
BABA   74.78 (-2.55%)
AMD   124.60 (+2.12%)
T   16.24 (+0.37%)
F   10.63 (+2.51%)
MU   77.28 (+1.52%)
CGC   0.55 (+1.81%)
GE   119.45 (+0.50%)
DIS   92.88 (+0.41%)
AMC   7.06 (+5.37%)
PFE   30.03 (+1.15%)
PYPL   58.64 (+0.29%)
XOM   103.11 (-0.76%)
S&P 500   4,567.56 (+0.28%)
DOW   35,539.90 (+0.35%)
QQQ   391.28 (+0.28%)
AAPL   189.88 (-0.27%)
MSFT   378.28 (-1.15%)
META   333.82 (-1.53%)
GOOGL   135.65 (-1.13%)
AMZN   146.44 (-0.40%)
TSLA   247.95 (+0.50%)
NVDA   482.19 (+0.83%)
NIO   7.23 (+0.28%)
BABA   74.78 (-2.55%)
AMD   124.60 (+2.12%)
T   16.24 (+0.37%)
F   10.63 (+2.51%)
MU   77.28 (+1.52%)
CGC   0.55 (+1.81%)
GE   119.45 (+0.50%)
DIS   92.88 (+0.41%)
AMC   7.06 (+5.37%)
PFE   30.03 (+1.15%)
PYPL   58.64 (+0.29%)
XOM   103.11 (-0.76%)
S&P 500   4,567.56 (+0.28%)
DOW   35,539.90 (+0.35%)
QQQ   391.28 (+0.28%)
AAPL   189.88 (-0.27%)
MSFT   378.28 (-1.15%)
META   333.82 (-1.53%)
GOOGL   135.65 (-1.13%)
AMZN   146.44 (-0.40%)
TSLA   247.95 (+0.50%)
NVDA   482.19 (+0.83%)
NIO   7.23 (+0.28%)
BABA   74.78 (-2.55%)
AMD   124.60 (+2.12%)
T   16.24 (+0.37%)
F   10.63 (+2.51%)
MU   77.28 (+1.52%)
CGC   0.55 (+1.81%)
GE   119.45 (+0.50%)
DIS   92.88 (+0.41%)
AMC   7.06 (+5.37%)
PFE   30.03 (+1.15%)
PYPL   58.64 (+0.29%)
XOM   103.11 (-0.76%)

TransCode Therapeutics (RNAZ) News Today

$0.25
+0.01 (+3.75%)
(As of 12:39 PM ET)
Compare
Today's Range
$0.23
▼
$0.25
50-Day Range
$0.23
▼
$2.55
52-Week Range
$0.15
▼
$23.40
Volume
1.17 million shs
Average Volume
1.90 million shs
Market Capitalization
$5.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
finance.yahoo.com logoTransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update
finance.yahoo.com - November 14 at 7:26 PM
finanznachrichten.de logoTransCode Therapeutics, Inc.: TransCode Therapeutics Withdraws Public Offering
finanznachrichten.de - October 31 at 8:43 AM
finance.yahoo.com logoTransCode Therapeutics Withdraws Public Offering
finance.yahoo.com - October 30 at 7:00 PM
finance.yahoo.com logoNasdaq Panel Grants TransCode Therapeutics Extension for Continued Listing on The Nasdaq Stock Market Subject to Conditions
finance.yahoo.com - October 27 at 12:00 PM
investorplace.com logoWhy Is TransCode Therapeutics (RNAZ) Stock Down 25% Today?
investorplace.com - October 27 at 9:12 AM
benzinga.com logoTransCode Therapeutics Announces Public Offering of Common Stock
benzinga.com - October 26 at 8:13 PM
finance.yahoo.com logoTransCode Therapeutics Announces Public Offering of Common Stock
finance.yahoo.com - October 26 at 8:13 PM
benzinga.com logoTransCode Therapeutics Stock (NASDAQ:RNAZ), Analyst Ratings, Price Targets, Predictions
benzinga.com - October 26 at 3:10 PM
finance.yahoo.com logoTransCode Therapeutics Announces Prolonged Survival in Murine Models with Glioblastoma Treated with Its Lead Candidate, TTX-MC138
finance.yahoo.com - October 26 at 8:22 AM
markets.businessinsider.com logoPromising Preliminary Clinical and Preclinical Results Bolster Buy Rating for TransCode Therapeutics: An Analysis by Emily Bodnar
markets.businessinsider.com - October 25 at 2:45 PM
finance.yahoo.com logoTransCode Therapeutics Reports Successful Treatment of Preclinical Melanoma Tumors with its Immunotherapy Candidate, TTX-RIGA
finance.yahoo.com - October 16 at 12:37 PM
finanznachrichten.de logoTransCode Therapeutics, Inc.: TransCode Therapeutics Announces Closing of $8.5 Million Public Offering
finanznachrichten.de - September 30 at 12:13 AM
finance.yahoo.com logoTransCode Therapeutics Announces Closing of $8.5 Million Public Offering
finance.yahoo.com - September 28 at 6:53 PM
benzinga.com logoWhy Transcode Therapeutics (RNAZ) Stock Is Down Nearly 70%
benzinga.com - September 26 at 2:06 PM
proactiveinvestors.com logoTranscode Therapeutics stock whipsaws lower after cut price placing
proactiveinvestors.com - September 26 at 9:06 AM
msn.com logoWhy Is TransCode Therapeutics (RNAZ) Stock Down 69% Today?
msn.com - September 26 at 9:06 AM
finance.yahoo.com logoTransCode Therapeutics Announces Pricing of $8 Million Public Offering
finance.yahoo.com - September 26 at 12:03 AM
markets.businessinsider.com logoGold Moves Lower; TransCode Therapeutics Shares Surge
markets.businessinsider.com - September 25 at 7:02 PM
marketbeat.com logo
marketbeat.com - September 25 at 3:35 PM
marketbeat.com logo
marketbeat.com - September 25 at 3:23 PM
marketwatch.com logoTransCode Therapeutics Shares Nearly Double on Positive Study Results
marketwatch.com - September 25 at 2:02 PM
proactiveinvestors.com logoTransCode Therapeutics stock skyrockets on positive brain cancer trial results
proactiveinvestors.com - September 25 at 2:02 PM
msn.com logoWhy Is TransCode Therapeutics (RNAZ) Stock Up 240% Today?
msn.com - September 25 at 2:02 PM
marketbeat.com logo
marketbeat.com - September 25 at 1:28 PM
marketbeat.com logo
marketbeat.com - September 25 at 1:28 PM
marketbeat.com logo
marketbeat.com - September 25 at 1:20 PM
marketbeat.com logo
marketbeat.com - September 25 at 12:33 PM
marketbeat.com logo
marketbeat.com - September 25 at 12:22 PM
marketbeat.com logo
marketbeat.com - September 25 at 12:10 PM
marketbeat.com logo
marketbeat.com - September 25 at 12:02 PM
marketbeat.com logo
marketbeat.com - September 25 at 11:57 AM
marketbeat.com logo
marketbeat.com - September 25 at 11:37 AM
marketbeat.com logo
marketbeat.com - September 25 at 11:29 AM
marketbeat.com logo
marketbeat.com - September 25 at 11:20 AM
marketbeat.com logo
marketbeat.com - September 25 at 11:16 AM
marketbeat.com logo
marketbeat.com - September 25 at 10:49 AM
marketbeat.com logo
marketbeat.com - September 25 at 10:40 AM
marketbeat.com logo
marketbeat.com - September 25 at 10:31 AM
marketbeat.com logo
marketbeat.com - September 25 at 10:21 AM
marketbeat.com logo
marketbeat.com - September 25 at 10:10 AM
marketbeat.com logo
marketbeat.com - September 25 at 10:01 AM
marketbeat.com logo
marketbeat.com - September 25 at 9:51 AM
marketbeat.com logo
marketbeat.com - September 25 at 9:46 AM
marketbeat.com logo
marketbeat.com - September 25 at 9:35 AM
markets.businessinsider.com logoWhy Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
markets.businessinsider.com - September 20 at 3:00 PM
finance.yahoo.com logoTransCode Therapeutics Announces First Subject Dosed with Radiolabeled TTX-MC138 in First-In-Human Clinical Trial
finance.yahoo.com - August 23 at 6:45 PM
finanznachrichten.de logoTransCode Therapeutics, Inc.: TransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update
finanznachrichten.de - August 15 at 11:48 PM
msn.com logoHC Wainwright & Co. Reiterates TransCode Therapeutics (RNAZ) Buy Recommendation
msn.com - August 15 at 6:47 PM
markets.businessinsider.com logoH.C. Wainwright Initiates a Buy Rating on TransCode Therapeutics (RNAZ)
markets.businessinsider.com - August 15 at 7:24 AM
finance.yahoo.com logoTransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update
finance.yahoo.com - August 14 at 9:23 PM
Get TransCode Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNAZ and its competitors with MarketBeat's FREE daily newsletter.



RNAZ Media Mentions By Week

RNAZ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RNAZ
News Sentiment
▼
1.43

0.74
▲
Average
Medical
News Sentiment

RNAZ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RNAZ Articles
This Week
▼
2

1
▲
RNAZ Articles
Average Week

Get TransCode Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNAZ and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:RNAZ) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -